Article

Impact of Different Modules of 21-Gene Assay in Early Breast Cancer Patients

2021-07-08

Abstract excerpt

<title>Abstract</title> <p><bold>Background:</bold> Young patients were under-evaluated in the construction and validation of the 21-gene Assay Recurrence Score (RS). Previous evidence suggested that RS performed differently according the ages of patients. Our study aimed to explore the molecular driving patterns in patients of different ages.<bold>Methods:</bold> A total of 1,078 estrogen receptor (ER)-positive...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: e5f16d3e-e342-5982-999f-50e85b1fe83b
DOI: 10.21203/rs.3.rs-652397/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Impact of Different Modules of 21-Gene Assay in Early Breast Cancer PatientsDOI 10.21203/rs.3.rs-652397/v1Read

A nomogram to predict the high-risk RS in HR+/HER2-breast cancer patients older than 50 years of ageSemantic proximity Read

Correlation Analysis of 21-Gene Recurrence Score with Gene Pathway Expression and Clinicopathological Features in Hormone Receptor-Positive Early-Stage Breast CancerSemantic proximity Read

21-Gene recurrence score decreases receipt of chemotherapy in ER+ early-stage breast cancer: an analysis of the NCDB 2010-2013.Semantic proximity Read

Utilization and impact of 21-gene recurrence score assay for breast cancer in clinical practice across the United States: lessons learned from the 2010 to 2012 National Cancer Data Base analysis.Semantic proximity Read

Prospective Validation of a 21-Gene Expression Assay in Breast CancerSemantic proximity Read

Adjuvant Chemotherapy Guided by a 21-Gene Expression Assay in Breast CancerSemantic proximity Read

The Clinical Impact of 21-Gene Recurrence Score on Treatment Decisions for Patients with Hormone Receptor-Positive Early Breast Cancer in KoreaSemantic proximity Read

Favorable Locoregional Control in Clinically Node- Negative Hormone-receptor Positive Breast Cancer With Low 21-gene Recurrence Scores: a Single Institutional Study With 10-year Follow-upSemantic proximity Read

PreciseBreast is prognostic for breast cancer recurrence in a 21-gene assay managed cohortSemantic proximity Read

Clinically relevant gene signatures provide independent prognostic information in older breast cancer patientsSemantic proximity Read

Clarification attempt of the mechanism of late recurrence by micro- and macro-analyses in estrogen receptor-positive breast cancerSemantic proximity Read

A 95-gene Signature Stratifies Recurrence Risk of Invasive Disease in ER-positive, HER2-negative, Node-negative Breast Cancer With Intermediate 21-gene Signature Recurrence ScoresSemantic proximity Read